Prevalence of Atrial Fibrillation in Patients with High CHADS2‐ and CHA2DS2VASc‐Scores: Anticoagulate or Monitor High‐Risk Patients?
Pacing and Clinical Electrophysiology2014Vol. 37(12), pp. 1651–1657
Citations Over TimeTop 11% of 2014 papers
T. Tischer, R. Schneider, Jörg Lauschke, Catharina Neßelmann, A. B. Klemm, Doreen Diedrich, Günther Kundt, Dietmar Bänsch
Abstract
The prevalence of AF increases with increasing CHADS2- and CHA2DS2VASc-score. In intermediate scores intensified monitoring may be recommended. In high scores, thromboembolic complications occurred irrespective of the presence of AF and anticoagulant therapy may be initiated irrespective of documented AF.
Related Papers
- → Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study(2016)148 cited
- → Changes in the CHA2DS2-VASC score as a predictor of incident atrial fibrillation in older Chinese individuals: the AF-CATCH study(2022)4 cited
- → Large variations in the use of oral anticoagulants in stroke patients with atrial fibrillation: a Swedish national perspective(2003)42 cited
- → Diabetes mellitus and congestive heart failure: the prevalence of congestive heart failure in patients with and without diabetes in Poland(2018)4 cited
- → Unequal prescription of anticoagulants among females and males with atrial fibrillation and similar stroke risk: Should we omit sex category from the CHA2DS2-VASc score?(2022)1 cited